Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Taribavirin hydrochloride is an orally active inosine monophosphate dehydrogenase inhibitor. Taribavirin hydrochloride is designed to concentrate within the liver to target HCV-infected hepatocytes while minimizing distribution within red blood cells and the development of hemolytic anemia [2].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 176,000 |
50 mg | 約6-8 週間 | ¥ 228,500 |
100 mg | 約6-8 週間 | ¥ 365,000 |
説明 | Taribavirin hydrochloride is an orally active inosine monophosphate dehydrogenase inhibitor. Taribavirin hydrochloride is designed to concentrate within the liver to target HCV-infected hepatocytes while minimizing distribution within red blood cells and the development of hemolytic anemia [2]. |
In vitro | Taribavirin hydrochloride (0-2 μM; 24 hours) obviously induces MCF-7 cell death. It recording half inhibitory effect (IC50) of 0.756 μM in MCF-7 cells [1]. |
分子量 | 279.68 |
分子式 | C8H14ClN5O4 |
CAS No. | 40372-00-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Taribavirin hydrochloride 40372-00-7 Others Taribavirin Hydrochloride Inhibitor inhibitor inhibit